Latest Breaking News On - Sivida corp - Page 1 : comparemela.com

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesZorica nastasicIcon bioscience incEyepoint pharmaceuticalsEyepoint pharmaceuticals incSivida corpPoint pharmaceuticalsIcon bioscienceEyepoint investor presentation januaryAge related macular degenerationNon proliferative diabetic retinopathyDiabetic macular edemaGeographic atrophySeeking alpha

Head-To-Head Survey: EyePoint Pharmaceuticals (NASDAQ:EYPT) & Seer (NASDAQ:SEER)

Head-To-Head Survey: EyePoint Pharmaceuticals (NASDAQ:EYPT) & Seer (NASDAQ:SEER)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRedwood citySalk instituteDiscovery life sciencesEyepoint pharmaceuticals incSeer incNews ratings for eyepoint pharmaceuticals dailySivida corpBroad instituteOregon health science universitySeer biosciences incSalk institute for biologicalEyepoint pharmaceuticalsGet free reportPoint pharmaceuticalsGiven seer

EyePoint Pharmaceuticals (NASDAQ:EYPT) versus HAVN Life Sciences (OTCMKTS:HAVLF) Financial Review

EyePoint Pharmaceuticals (NASDAQ:EYPT) versus HAVN Life Sciences (OTCMKTS:HAVLF) Financial Review
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLife sciences incEyepoint pharmaceuticals incEyepoint pharmaceuticalsNews ratings for eyepoint pharmaceuticals dailySivida corpLife sciencesGet free reportPoint pharmaceuticalsGiven eyepoint pharmaceuticalSciences incEyepoint pharmaceuticals daily

EyePoint Pharmaceuticals (NASDAQ:EYPT) Upgraded by Zacks Investment Research to Buy

EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday, Zacks.com reports. The firm presently has a $10.00 price objective on the stock. Zacks Investment Research‘s target price suggests a potential upside of 3.20% […]

United statesHong kongUnited kingdomZurcher kantonalbank zurich cantonalbankFourthought financialSivida corpZacks investment researchEyepoint pharmaceuticals company profile get ratingCantor fitzgeraldEyepoint pharmaceuticalsCitigroup incParagon capital management ltdEyepoint pharmaceuticals incHong kong ltdGet ratingInvestment research

Research Analysts Upgrades for May 30th (AUDC, BGCP, CGEN, DAC, EBKDY, ELS, ENFN, ERAS, ESSA, EVGO)

Research Analysts’ upgrades for Monday, May 30th: AudioCodes (NASDAQ:AUDC) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. BGC Partners (NASDAQ:BGCP) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Compugen (NASDAQ:CGEN) was upgraded by analysts at StockNews.com from a sell rating to a hold […]

United statesPerusahaan perseroan perseroEnfusion incCorporate office properties trustStratus propertiesEvgo servicesResearch analystEquity lifestyle properties incErste bank der musterVodafone group publicEyepoint pharmaceuticalsBancorp incCitigroup incErste group bankNedbank groupSivida corp